clock menu more-arrow no yes

Filed under:

Bayer sells division to Boston Scientific

BERLIN (AP) — Germany’s Bayer AG says it’s selling its interventional division to the Boston Scientific Corp. for $415 million so that it can focus on growth in other areas.

The Leverkusen-based company said Thursday the sale includes its AngioJet system used to remove blood clots, its Jetstream system for arterial disease treatment, and the Fetch 2 Aspiration Catheter used in cardiology, radiology and peripheral vascular procedures.

Bayer says the sale will allow its HealthCare unit to focus more on growing its radiology and diabetes care business segments.

Natick, Massachusetts-based Boston Scientific says the acquisition is expected to expand the company’s access to customers in need of such treatments.

The transaction is subject to antitrust approval and is expected to clear in the second half of 2014.

Bayer to buy Merck consumer business for $14.2B

Abbott may sell off older drugs

Merck makes deal worth at least $600M with Santen

Akorn plans $440M acquisition of VersaPharm